CLINICAL_TRIALS
trial_result
· 2012-06-14
Clinical Trial Update: Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 clinical trial investigating MK-0431/ONO-5435 in patients with Type 2 Diabetes Mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED